Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer (Q35206302)

7 August 2017

Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer (English)

1 reference

7 August 2017

21

1 reference

7 August 2017

Anne-Lise Børresen-Dale

19

object named as

Anne-Lise Borresen-Dale

0 references

Jan Alsner

17

object named as

Jan Alsner

1 reference

7 August 2017

3

Funda Meric-Bernstam

1 reference

Ana Maria Gonzalez-Angulo

7 August 2017

1

object named as

Ana M Gonzalez-Angulo

1 reference

7 August 2017

20

Gabriel N Hortobagyi

1 reference

7 August 2017

22

Gordon B Mills

1 reference

7 August 2017

2

Bryan T Hennessy

1 reference

7 August 2017

Aysegul Sahin

4

1 reference

7 August 2017

Wenbin Liu

5

1 reference

7 August 2017

Zhenlin Ju

6

1 reference

7 August 2017

Mark S Carey

7

1 reference

7 August 2017

Simen Myhre

8

1 reference

7 August 2017

Corey Speers

9

1 reference

7 August 2017

Lei Deng

10

1 reference

7 August 2017

Russell Broaddus

11

1 reference

7 August 2017

Ana Lluch

12

1 reference

7 August 2017

Sam Aparicio

13

1 reference

7 August 2017

Powel Brown

14

1 reference

7 August 2017

Lajos Pusztai

15

1 reference

7 August 2017

W Fraser Symmans

16

1 reference

7 August 2017

Jens Overgaard

18

1 reference

7 August 2017

language of work or name

1 reference

8 July 2011

1 reference

7 August 2017

1 reference

7 August 2017

8

1 reference

7 August 2017

11

1 reference

7 August 2017

1

1 reference

Creative Commons Attribution 2.0 Generic

7 August 2017

start time

8 July 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1559-0275-8-11

0 references

cites work

A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Pharmacodynamic markers of perifosine efficacy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Concordance among gene-expression-based predictors for breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

The molecular portraits of breast tumors are conserved across microarray platforms

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Mechanism and function of deubiquitinating enzymes

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Single cell proteomics for personalised medicine

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

A gene-expression signature as a predictor of survival in breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Correlation between protein and mRNA abundance in yeast

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Cluster analysis and display of genome-wide expression patterns

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

The Measurement of Observer Agreement for Categorical Data

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Non-parametric quantification of protein lysate arrays.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170272

Penalized likelihood in Cox regression

26 September 2018

1 reference

12 December 2020

Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors

1 reference

12 December 2020

Appearance of quasiequivalent solutions, in a generalization of the Kruskal scale technic, to metric spaces using a Minkowski metric

1 reference

12 December 2020

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

12 December 2020

Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1559-0275-8-11

1 reference

Dimensions Publication ID

7 August 2017

0 references

1 reference

7 August 2017

1 reference